If you are not a current client of Bereskin & Parr LLP, please do not include any information in this email that you or someone else considers confidential. You do not become a client of the firm until the firm agrees to act for you and confirms representation in writing. Until that time what you send us cannot be protected from disclosure.
Articles
Recent Articles
Article February 1, 2023
2022 Year in Review: Key Trademark Cases in Canada
Article January 26, 2023
2022 Year in Review: Electrical & Computer Technology
Article January 17, 2023
2022 Year in Review: Canadian Copyright
Article January 16, 2023
Chirality Matters: Dismissal of Janssen’s Judicial Review Confirms Enantiomers Are Not “Innovative...
Article January 12, 2023
Significant Changes to the European Patent System Are Coming in 2023 – Here is What Canadian Applicants...
Article January 10, 2023
Canadian Grant Agency Raises Clinical Trial Reporting Requirements
Article December 23, 2022
Patented Medicines Regulations: The Problem Is Not in Collecting the Data, but in How You Use I...
Article December 15, 2022
Preparing the Expert Report in a Patent Case – A Collaborative Exercise to be Approached with C...
Article December 12, 2022
Getting Transparent About Transparency: Canadian Registration and Reporting of Clinical Trials
Article December 9, 2022
Crocs’ Design Takes a Bite Out of the Competition
Article December 6, 2022
Skating to Where the Puck Is Going to Be - How the IRAP ‘IP Assist’ Program Can Help With Startup...